Suppr超能文献

母体对胎儿同种异体抗原的反应性与新生儿免疫反应及随后的过敏性疾病有关。

Maternal reactivity to fetal alloantigens is related to newborn immune responses and subsequent allergic disease.

作者信息

Prescott S L, Taylor A, Roper J, Wahdan A, Noakes P, Thornton C, Dunstan J, Upham J W

机构信息

School of Paediatrics and Child Health Research, University of Western Australia, Perth, WA, Australia.

出版信息

Clin Exp Allergy. 2005 Apr;35(4):417-25. doi: 10.1111/j.1365-2222.2005.02171.x.

Abstract

BACKGROUND

Maternal allergy confers stronger allergy risk (than paternal allergy) suggesting that maternal patterns of immune response can directly influence immune development in offspring. Women prone to allergic immune responses to allergens may also have altered immune responses to other antigens including fetal antigens.

OBJECTIVE

This exploratory study examines relationships between maternal immune responses to fetal antigens and the subsequent risk of allergy.

METHODS

Mononuclear cells (MNC) were collected from 36 mother-infant pairs to compare maternal (and fetal) cellular immune responses to alloantigens (fetal, maternal or unrelated donor [URD]), and allergens in allergic (18 pairs) and non-allergic (18 pairs) mothers. Thirty children had documented allergic outcomes at 6 years of age.

RESULTS

In this population, allergic outcomes in the offspring were associated more strongly with materno-fetal immune interactions than with a maternal family history of allergy. Specifically, allergic disease at 6 years of age was associated with significantly higher maternal responses to fetal alloantigens (lymphoproliferation, P=0.008; IL-13, P=0.02 and IFN-gamma, P=0.015), whereas associations with maternal allergy did not reach significance (P=0.07). Fetal IFN-gamma alloantigen responses were significantly correlated with the degree of human lymphocyte antigen (HLA) mismatch (maternal HLA class II antibodies) (tau=0.3, P=0.03). The capacity of the fetus to produce IL-13 (tau=0.4, P=0.001) and IL-10 (tau=0.3, P=0.029) was directly related to the level of these cytokines produced by the mother in response to fetal antigens. Allergic mothers showed a non-significant trend for stronger lymphoproliferation to fetal alloantigens. The number of previous pregnancies (gravidity) was associated with stronger maternal responses to fetal alloantigens, as shown by lymphoproliferation (Kendall tau=0.3, P=0.04) and IFN-gamma (tau=0.3, P=0.04) synthesis, but did not affect fetal responses to the various stimuli.

CONCLUSIONS

Maternal responses to fetal antigens were related to fetal immune responses and subsequent allergy. This novel observation suggests that events at the materno-fetal interface have an important influence on early immune development and should be investigated further.

摘要

背景

母亲过敏比父亲过敏带来更强的过敏风险,这表明母亲的免疫反应模式可直接影响后代的免疫发育。容易对过敏原产生过敏免疫反应的女性,对包括胎儿抗原在内的其他抗原的免疫反应也可能发生改变。

目的

本探索性研究旨在探讨母亲对胎儿抗原的免疫反应与随后的过敏风险之间的关系。

方法

收集36对母婴的单核细胞(MNC),以比较母亲(及胎儿)对同种异体抗原(胎儿、母亲或无关供体[URD])以及过敏母亲(18对)和非过敏母亲(18对)中的过敏原的细胞免疫反应。30名儿童在6岁时有记录的过敏结局。

结果

在该人群中,后代的过敏结局与母婴免疫相互作用的关联比与母亲的过敏家族史更强。具体而言,6岁时的过敏性疾病与母亲对胎儿同种异体抗原的反应显著更高有关(淋巴细胞增殖,P = 0.008;IL - 13,P = 0.02;IFN - γ,P = 0.015),而与母亲过敏的关联未达到显著水平(P = 0.07)。胎儿对IFN - γ同种异体抗原的反应与人类淋巴细胞抗原(HLA)错配程度(母亲HLA II类抗体)显著相关(tau = 0.3,P = 0.03)。胎儿产生IL - 13(tau = 0.4,P = 0.001)和IL - 10(tau = 0.3,P = 0.029)的能力与母亲对胎儿抗原反应产生的这些细胞因子水平直接相关。过敏母亲对胎儿同种异体抗原的淋巴细胞增殖有更强的趋势,但不显著。既往妊娠次数(妊娠次数)与母亲对胎儿同种异体抗原的反应更强有关,如淋巴细胞增殖(肯德尔tau = 0.3,P = 0.04)和IFN - γ(tau = 0.3,P = 0.04)合成所示,但不影响胎儿对各种刺激的反应。

结论

母亲对胎儿抗原的反应与胎儿免疫反应及随后的过敏有关。这一新颖的观察结果表明,母婴界面的事件对早期免疫发育有重要影响,应进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验